Diabetic retinopathy and insulin glargine.
Chantelau
E
E
D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000209:etiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D016032:Randomized Controlled Trials as Topic
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine
Diabet Med. 2001 Mar;18(3):178-84
11318837
Diabetologia. 2009 Sep;52(9):1778-88
19526210
N Engl J Med. 1993 Sep 30;329(14):977-86
8366922